Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage Cancer

Key Points

• The aim is to develop a risk prediction model for taxane-induced peripheral neuropathy (TIPN) in patients with early-stage cancer.
• Cohort study design involving participants with early-stage cancer
• Assessment of baseline risk factors associated with TIPN
• Development of a risk prediction model based on identified factors
• Identification of significant baseline risk factors for TIPN
• Creation of a predictive model to estimate TIPN risk
• Potential for guiding treatment decisions and monitoring symptoms